MUFG Securities EMEA’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Buy |
+1,738
| New | +$136K | 0.17% | 161 |
|
|
2024
Q4 | – | Sell |
-125,000
| Closed | -$8.25M | – | 174 |
|
|
2024
Q3 | $8.25M | Buy |
+125,000
| New | +$8.25M | 0.3% | 83 |
|
|
2022
Q4 | – | Sell |
-90,000
| Closed | -$7.44M | – | 126 |
|
|
2022
Q3 | $7.44M | Buy |
+90,000
| New | +$7.44M | 0.14% | 23 |
|
|
2022
Q2 | – | Sell |
-10,400
| Closed | -$1.22M | – | 112 |
|
|
2022
Q1 | $1.22M | Hold |
10,400
| – | – | 0.02% | 67 |
|
|
2021
Q4 | $1.35M | Sell |
10,400
-28,000
| -73% | -$3.63M | 0.02% | 102 |
|
|
2021
Q3 | $4.35M | Sell |
38,400
-113,200
| -75% | -$12.8M | 0.05% | 140 |
|
|
2021
Q2 | $15.7M | Sell |
151,600
-97,000
| -39% | -$10M | 0.15% | 82 |
|
|
2021
Q1 | $20.8M | Sell |
248,600
-193,000
| -44% | -$16.1M | 0.17% | 99 |
|
|
2020
Q4 | $40.3M | Sell |
441,600
-140,720
| -24% | -$12.8M | 0.31% | 61 |
|
|
2020
Q3 | $46.5M | Buy |
582,320
+290,720
| +100% | +$23.2M | 0.44% | 37 |
|
|
2020
Q2 | $20.2M | Sell |
291,600
-341,100
| -54% | -$23.6M | 0.18% | 100 |
|
|
2020
Q1 | $39.8M | Buy |
632,700
+617,700
| +4,118% | +$38.8M | 0.4% | 47 |
|
|
2019
Q4 | $1.17M | Sell |
15,000
-145,800
| -91% | -$11.3M | 0.01% | 405 |
|
|
2019
Q3 | $11.8M | Buy |
+160,800
| New | +$11.8M | 0.14% | 105 |
|
|
2018
Q4 | – | Sell |
-233,328
| Closed | -$13.5M | – | 481 |
|
|
2018
Q3 | $13.5M | Buy |
233,328
+232,620
| +32,856% | +$13.5M | 0.19% | 80 |
|
|
2018
Q2 | $34K | Buy |
+708
| New | +$34K | ﹤0.01% | 315 |
|
|
2018
Q1 | – | Sell |
-60,000
| Closed | -$2.25M | – | 183 |
|
|
2017
Q4 | $2.25M | Buy |
+60,000
| New | +$2.25M | 0.05% | 105 |
|